• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Nuance Communications Inc.

How Olympus is using AI to find patients for its COPD device

August 3, 2021 By Chris Newmarker

Olympus recently announced its SeleCT Connect program, which uses diagnostic imaging AI to automatically screen which people might benefit from its Spiration valve system. Spiration is an FDA-designated breakthrough device for treating chronic obstructive pulmonary disease (COPD) patients. SeleCT Connect — offered as part of Olympus’ SeleCT quantitative computer tomography (QCT) analysis service — is […]

Filed Under: Big Data, Cardiovascular, Diagnostics, Electronic Medical Records (EMR), Featured, Health Technology, Imaging, Respiratory, Software / IT Tagged With: AI, artificial intelligence, Imbio, Nuance Communications Inc., Olympus

MedTech 100 roundup: Industry skies to all-time high

April 19, 2021 By Sean Whooley

The medtech industry hit a slight lull in the early stages of 2021 and, after signs of a rebound, it has soared beyond levels ever before seen. MassDevice‘s MedTech 100 Index had been building up steam in the month of April, rising from 102.16 points at the beginning of March all the way to 109.39 to […]

Filed Under: Business/Financial News, Featured, Funding Roundup, Initial Public Offering (IPO), MassDevice Earnings Roundup, Mergers & Acquisitions, Wall Street Beat Tagged With: Align Technology, Amgen, DiaSorin, Five Prime Therapeutics, Luminex, Medline Industries Inc., MedTech 100 Index, Microsoft, Nuance Communications Inc., Siemens Healthineers, Thermo Fisher Scientific, Varian Medical Systems, Vicarious Surgical

Microsoft spending $19.7B on Nuance and its AI for healthcare providers

April 12, 2021 By Sean Whooley

Microsoft announced today that it will acquire Nuance Communications and its AI-based software used by healthcare providers. Under the agreement, Microsoft will buy Nuance at $56 per share, representing a 23% premium to Nuance’s closing price on Friday, April 9, 2021. The all-cash transaction is valued at $19.7 billion, inclusive of Nuance’s debt, according to […]

Filed Under: Big Data, Business/Financial News, Digital Health, Electronic Medical Records (EMR), Featured, Health Information Technology, Health Technology, Mergers & Acquisitions, Software / IT Tagged With: Microsoft, Nuance Communications Inc.

Biolase CEO succession continues | Personnel Moves

July 21, 2015 By Fink Densford

Biolase (NSDQ:BIOL) said earlier this month that CEO Jeffery Nugent has resigned from both his position as CEO and the board of directors, effective July 12, to be replaced by Harold Flynn. Irvine, Calif.-based Biolase picked up Flynn, the former president of Zimmer Dental (NYSE:ZMH), in May to replace Nugent, who the company said had stepped in to […]

Filed Under: Business/Financial News Tagged With: Biolase, Iluminoss, iRhythm Technologies Inc., nContact Inc., Nuance Communications Inc., Personnel Moves, SANUWAVE Health Inc., Smartrac, Theralase, Zimmer Biomet

Diabetes: Glooko links up with Wal-Mart | Wall Street Beat

September 27, 2012 By MassDevice staff Leave a Comment

MassDevice.com Wall Street Beat

Filed Under: News Well, Wall Street Beat Tagged With: Apple, Freedom Meditech, Glooko, Infoscitex, Neurometrix, Nuance Communications Inc., QuadraMed, Vivonics, Wal-Mart

MassDevice.com +3 | The top 3 med-tech stories for July 30, 2012

July 30, 2012 By MassDevice staff Leave a Comment

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.

If you read nothing else today, make sure you’re still in the know with MassDevice +3.

Filed Under: Health Information Technology, Legal News, News Well Tagged With: Nuance Communications Inc., Nuvasive

Taming the tsunami of clinical data: Can speech recognition change the way medicine is practiced?

July 30, 2012 By Brad Perriello Leave a Comment

Nuance Communications Nick van Terheyden

Imagine a future in which a software program, tapped into a database containing every electronic medical record in the country, helps guide your every interaction with your doctor.

For Dr. Nick van Terheyden, chief medical information officer for Nuance Communications (NSDQ:NUAN), that’s not as far-fetched as it sounds.

Filed Under: Health Information Technology, News Well Tagged With: Nuance Communications Inc.

Nuance Communications VP of health care solutions marketing Carina Edwards

July 16, 2012 By MassDevice Contributors Network Leave a Comment

In a recent interview with Nuance’s Carina Edwards, she took MassDevice through a tour of the shift from speech recognition to speech understanding, how artificial intelligence will revolutionize medical coding and what the Jeopardy-winning Watson supercomputer might be able to do for medicine.

Filed Under: Uncategorized Tagged With: Main Videos, Nuance Communications Inc.

St. Jude Medical rebounds after “Greek tragedy” | Wall Street Beat

March 7, 2012 By MassDevice staff Leave a Comment

MassDevice.com Wall Street Beat

Shares of St. Jude Medical (NYSE:STJ) clawed back some of the value lost yesterday in what 1 waggish analyst termed a “Greek tragedy.”

STJ shares closed down 3.3% yesterday at $39.96 when the company revealed a $56 million writedown after a Greek distributor failed to pay up for an estimated 2 years worth of sales.

Filed Under: News Well, Wall Street Beat Tagged With: Advanced Cell Technology Inc., Allezoe Medical Holdings, Amgen, Baxter, BG Medicine Inc., CareFusion Corp., GE Capital, Hillrom, MAKO Surgical Corp., Micromet, Nordion Inc., Nuance Communications Inc., Sequent Medical, stjudemedical, Syneron Medical Ltd., Transcend Services, TransPharma Medical, Zeltiq

Newer artificial hips may not last as long | MassDevice.com On Call

November 30, 2011 By MassDevice staff Leave a Comment

MassDevice On Call

MASSDEVICE ON CALL — Newer generations of artificial hips may not be as good as their predecessors, according to research funded by the FDA.

Modern hip replacement devices using metal-on-metal joints or ceramic-on-ceramic joints may wear out faster than metal-on-polyethylene or ceramic-on-polyethylene models.

In a comparative study examining the records of more than 3,000 patients and 3,400 hips, the overall results found no advantage in the more expensive, newer artificial hips, but did see a higher rate of revision surgery in some of the results.

Filed Under: Diagnostics, Food & Drug Administration (FDA), News Well, Pharmaceutical Tagged With: Hips, Insurance, Nuance Communications Inc., Taris Biomedical

Job cuts, BSX’s new CEO and tax woes, JNJ’s heart venture, bribery accusations against Nuance, mesh makers’ defense and sweeping patent reforms made headlines this week | MassDevice.com +7

September 17, 2011 By MassDevice staff Leave a Comment

Plus Seven

Say hello to MassDevice +7, a bite-sized view of the top seven med-tech stories of the week. This latest feature of MassDevice.com’s coverage highlights our seven biggest and most influential stories from the week’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.

If you read nothing else this weekend, make sure you’re still in the know with MassDevice +7.

Filed Under: Legal News, News Well, Patent Infringement, Women's Health Tagged With: Boston Scientific, Johnson and Johnson, Nuance Communications Inc., Personnel Moves

  • Page 1
  • Page 2
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy